Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| F. Hoffmann-La Roche AG | Kaiseraugst, Switzerland | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 21, 2025 · 8 inspections |
| F. Hoffmann-La Roche AG | Basel, Switzerland | Makes it, makes the active ingredient and tests it | Problems found, fixed voluntarilyMay 9, 2025 · 9 inspections |
Recalls
- Apr 20, 2021 · Class III · Genentech Inc
Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.
Lots: Lot #: B1001B05; B1001B08, Exp. Feb-2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Risdiplam: every company that makes it
- Form
- powder, for solution, oral
- Strength
- 0.75 mg per 1 mL
- Approval
- NDA NDA213535
- On the market since
- Aug 7, 2020
- Package NDCs
50242-175-07- Official label
- DailyMed (National Library of Medicine), updated Nov 2, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?